Will ocean acidification affect the early ontogeny of a tropical oviparous elasmobranch (Hemiscyllium ocellatum)?

Atmospheric CO2 is increasing due to anthropogenic causes. Approximately 30% of this CO2 is being absorbed by the oceans and is causing ocean acidification (OA). The effects of OA on calcifying organisms are starting to be understood, but less is known about the effects on non-calcifying organisms, notably elasmobranchs. One of the few elasmobranch species that has been studied with respect to OA is the epaulette shark, Hemiscyllium ocellatum. Mature epaulette sharks can physiologically and behaviourally tolerate prolonged exposure to elevated CO2, and this is thought to be because they are routinely exposed to diurnal decreases in O2 and probably concomitant increases in CO2 in their coral reef habitats. It follows that H. ocellatum embryos, while developing in ovo on the reefs, would have to be equally if not more tolerant than adults because they would not be able to escape such conditions. Epaulette shark eggs were exposed to either present-day control conditions (420 µatm) or elevated CO2 (945 µatm) and observed every 3 days from 10 days post-fertilization until 30 days post-hatching. Growth (in square centimetres per day), yolk usage (as a percentage), tail oscillations (per minute), gill movements (per minute) and survival were not significantly different in embryos reared in control conditions when compared with those reared in elevated CO2 conditions. Overall, these findings emphasize the importance of investigating early life-history stages, as the consequences are expected to transfer not only to the success of an individual but also to populations and their distribution patterns

Elasmobranch qPCR reference genes: a case study of hypoxia preconditioned epaulette sharks

<p>Abstract</p> <p>Background</p> <p>Elasmobranch fishes are an ancient group of vertebrates which have high potential as model species for research into evolutionary physiology and genomics. However, no comparative studies have established suitable reference genes for quantitative PCR (qPCR) in elasmobranchs for any physiological conditions. Oxygen availability has been a major force shaping the physiological evolution of vertebrates, especially fishes. Here we examined the suitability of 9 reference candidates from various functional categories after a single hypoxic insult or after hypoxia preconditioning in epaulette shark (<it>Hemiscyllium ocellatum</it>).</p> <p>Results</p> <p>Epaulette sharks were caught and exposed to hypoxia. Tissues were collected from 10 controls, 10 individuals with single hypoxic insult and 10 individuals with hypoxia preconditioning (8 hypoxic insults, 12 hours apart). We produced sequence information for reference gene candidates and monitored mRNA expression levels in four tissues: cerebellum, heart, gill and eye. The stability of the genes was examined with analysis of variance, geNorm and NormFinder. The best ranking genes in our study were <it>eukaryotic translation elongation factor 1 beta </it>(<it>eef1b</it>), <it>ubiquitin </it>(<it>ubq</it>) and <it>polymerase (RNA) II (DNA directed) polypeptide F </it>(<it>polr2f</it>). The performance of the <it>ribosomal protein L6 </it>(<it>rpl6</it>) was tissue-dependent. Notably, in one tissue the analysis of variance indicated statistically significant differences between treatments for genes that were ranked as the most stable candidates by reference gene software.</p> <p>Conclusions</p> <p>Our results indicate that <it>eef1b </it>and <it>ubq </it>are generally the most suitable reference genes for the conditions and tissues in the present epaulette shark studies. These genes could also be potential reference gene candidates for other physiological studies examining stress in elasmobranchs. The results emphasise the importance of inter-group variation in reference gene evaluation.</p

Acidosis Maintains the Function of Brain Mitochondria in Hypoxia-Tolerant Triplefin Fish: A Strategy to Survive Acute Hypoxic Exposure?

The vertebrate brain is generally very sensitive to acidosis, so a hypoxia-induced decrease in pH is likely to have an effect on brain mitochondria (mt). Mitochondrial respiration (JO2) is required to generate an electrical gradient (ΔΨm) and a pH gradient to power ATP synthesis, yet the impact of pH modulation on brain mt function remains largely unexplored. As intertidal fishes within rock pools routinely experience hypoxia and reoxygenation, they would most likely experience changes in cellular pH. We hence compared four New Zealand triplefin fish species ranging from intertidal hypoxia-tolerant species (HTS) to subtidal hypoxia-sensitive species (HSS). We predicted that HTS would tolerate acidosis better than HSS in terms of sustaining mt structure and function. Using respirometers coupled to fluorimeters and pH electrodes, we titrated lactic-acid to decrease the pH of the media, and simultaneously recorded JO2, ΔΨm, and H+ buffering capacities within permeabilized brain and swelling of mt isolated from non-permeabilized brains. We then measured ATP synthesis rates in the most HTS (Bellapiscus medius) and the HSS (Forsterygion varium) at pH 7.25 and 6.65. Mitochondria from HTS brain did have greater H+ buffering capacities than HSS mt (∼10 mU pH.mgprotein-1). HTS mt swelled by 40% when exposed to a decrease of 1.5 pH units, and JO2 was depressed by up to 15% in HTS. However, HTS were able to maintain ΔΨm near -120 mV. Estimates of work, in terms of charges moved across the mt inner-membrane, suggested that with acidosis, HTS mt may in part harness extra-mt H+ to maintain ΔΨm, and could therefore support ATP production. This was confirmed with elevated ATP synthesis rates and enhanced P:O ratios at pH 6.65 relative to pH 7.25. In contrast, mt volumes and ΔΨm decreased downward pH 6.9 in HSS mt and paradoxically, JO2 increased (∼25%) but ATP synthesis and P:O ratios were depressed at pH 6.65. This indicates a loss of coupling in the HSS with acidosis. Overall, the mt of these intertidal fish have adaptations that enhance ATP synthesis efficiency under acidic conditions such as those that occur in hypoxic or reoxygenated brain

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Dimethyl fumarate (DMF) inhibits inflammasome-mediated inflammation and has been proposed as a treatment for patients hospitalised with COVID-19. This randomised, controlled, open-label platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing multiple treatments in patients hospitalised for COVID-19 (NCT04381936, ISRCTN50189673). In this assessment of DMF performed at 27 UK hospitals, adults were randomly allocated (1:1) to either usual standard of care alone or usual standard of care plus DMF. The primary outcome was clinical status on day 5 measured on a seven-point ordinal scale. Secondary outcomes were time to sustained improvement in clinical status, time to discharge, day 5 peripheral blood oxygenation, day 5 C-reactive protein, and improvement in day 10 clinical status. Between 2 March 2021 and 18 November 2021, 713 patients were enroled in the DMF evaluation, of whom 356 were randomly allocated to receive usual care plus DMF, and 357 to usual care alone. 95% of patients received corticosteroids as part of routine care. There was no evidence of a beneficial effect of DMF on clinical status at day 5 (common odds ratio of unfavourable outcome 1.12; 95% CI 0.86-1.47; p = 0.40). There was no significant effect of DMF on any secondary outcome

Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Dimethyl fumarate (DMF) inhibits inflammasome-mediated inflammation and has been proposed as a treatment for patients hospitalised with COVID-19. This randomised, controlled, open-label platform trial (Randomised Evaluation of COVID-19 Therapy [RECOVERY]), is assessing multiple treatments in patients hospitalised for COVID-19 (NCT04381936, ISRCTN50189673). In this assessment of DMF performed at 27 UK hospitals, adults were randomly allocated (1:1) to either usual standard of care alone or usual standard of care plus DMF. The primary outcome was clinical status on day 5 measured on a seven-point ordinal scale. Secondary outcomes were time to sustained improvement in clinical status, time to discharge, day 5 peripheral blood oxygenation, day 5 C-reactive protein, and improvement in day 10 clinical status. Between 2 March 2021 and 18 November 2021, 713 patients were enroled in the DMF evaluation, of whom 356 were randomly allocated to receive usual care plus DMF, and 357 to usual care alone. 95% of patients received corticosteroids as part of routine care. There was no evidence of a beneficial effect of DMF on clinical status at day 5 (common odds ratio of unfavourable outcome 1.12; 95% CI 0.86-1.47; p = 0.40). There was no significant effect of DMF on any secondary outcome

Neuronal oxidative hypometabolism in the brainstem of the epaulette shark (Hemiscyllium ocellatum) in response to hypoxic pre-conditioning

Reduced oxidative demand or neuronal hypometabolism is a neuroprotective strategy used by several anoxia and hypoxia-tolerant species. The epaulette shark, Hemiscyllium ocellatum inhabits shallow reef platforms that can become hypoxic. Hypoxic pre-conditioning (eight cycles of 0.34 mg O/l for 120 min, 12 h apart) was used to determine whether a reduction in oxidative metabolism could be elicited in the epaulette shark brain. Hypoxic pre-conditioning resulted in a significant overall reduction in oxidative activity in coronal sections of the brainstem, but key nuclei displayed heterogeneous levels of oxidative metabolism. Motor nuclei had significantly lower levels of oxidative activity while sensory nuclei did not. The epaulette shark's ability to enter this state of hypometabolism in response to hypoxic pre-conditioning revealed a neuroprotective mechanism, which would not only reduce neuronal damage during hypoxic exposure but also minimise re-oxygenation injury. Copyright (C) 2000

Increased nitric oxide synthase in the vasculature of the epaulette shark brain following hypoxia

EPAULETTE sharks inhabiting reef platforms are exposed to hypoxic and hyperoxic cycles. The adaptive mechanisms used to prevent neurological damage during these cycles have not been examined. Nitric oxide has a neuroprotective role in some hypoxia-tolerant species. We examined epaulette brains following a severe experimental hypoxic regimen (0.39 mgO(2)/l for 2 h) and compared nitric oxide synthase (NOS) expression with that in normoxic controls using NADPH-diaphorase staining. Intense NOS activity occurred in microvasculature following exposure to a severely hypoxic environment in contrast to the low levels seen in controls. We established for the first time that the epaulette shark was hypoxia-tolerant because there was no delayed phase of neuronal apoptosis. Enhanced NOS production in response to hypoxia may cause vasodilation, which would maintain the appropriate metabolic environment for continued neuronal survival during exposure to hypoxia. NeuroReport 10:1707-1712 (C) 1999 Lippincott Williams & Wilkins

Intermittent normobaric hypoxia alters substrate partitioning and muscle oxygenation in obese individuals: implications for fat burning

International audienceThis single-blind, crossover study aimed to measure and evaluate the short-term metabolic responses to continuous and intermittent hypoxic patterns in individuals with obesity. Indirect calorimetry was used to quantify changes in resting metabolic rate (RMR), carbohydrate (CHO ox , %CHO) and fat oxidation (FAT ox , %FAT) in nine individuals with obesity pre- and post-: (i) breathing normoxic air [normoxic sham control (NS-control)]; (ii) breathing continuous hypoxia (CH); or (iii) breathing intermittent hypoxia (IH). A mean peripheral oxygen saturation (SpO 2 ) of 80-85% was achieved over a total of 45 minutes of hypoxia. Throughout each intervention pulmonary gas exchanges - oxygen consumption ( ), carbon dioxide production ( - and deoxyhaemoglobin concentration ( [HHb]) in the vastus lateralis were measured. Both RMR and CHO ox measured pre- and post-interventions were unchanged following each treatment: NS-control; CH; or IH (all p > 0.05). Conversely, a significant increase in FAT ox was evident between pre- and post-IH (+44%, p = 0.048). While the mean [HHb] values significantly increased during both IH and CH ( p<0.05), the greatest zenith of [HHb] was achieved in IH compared to CH ( p = 0.002). Furthermore, there was a positive correlation between ∆[HHb] and the shift in FAT ox measured pre- and post-intervention. It is suggested that during IH the increased bouts of muscle hypoxia, revealed by elevated ∆[HHb], coupled with cyclic periods of excess post-hypoxia oxygen consumption (EPHOC, inherent to the intermittent pattern) played a significant role in driving the increase in FAT ox post-IH

Intermittent hypoxia revisited: a promising non-pharmaceutical strategy to reduce cardio-metabolic risk factors?

International audienc